JHS Svendgaard Laboratories concluded its postal ballot proceedings on July 29, 2026, after shareholders voted on a resolution to modify the utilization of funds raised through a preferential issue of equity shares and fully convertible warrants. The outcome of this vote determines whether the company can reallocate capital originally earmarked for specific purposes, impacting its strategic flexibility and future investment plans. The Board of Directors initiated this process following a meeting held on June 25, 2026, requiring shareholder approval under Section 110 read with Section 108 of the Companies Act, 2013.

The voting process was conducted via remote e-voting in compliance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Secretarial Standard on General Meetings (SS-2). National Securities Depository Limited (NSDL) provided the e-voting facility and technical services for the ballot. Mr. Mohit Dahiya, Practicing Company Secretary of M/s. Dahiya & Associates, New Delhi, was appointed as the Scrutinizer to ensure the process remained fair and transparent.

Voting Timeline and Details

The postal ballot notice, along with the explanatory statement and e-voting instructions, was dispatched to shareholders on June 29, 2026. The cut-off date for determining voting entitlements was June 26, 2026. An advertisement confirming the dispatch of the notice was published in Business Standard (Hindi & English) on June 30, 2026, pursuant to Rule 22 of the Companies (Management and Administration) Rules, 2014.

Shareholders registered their votes electronically starting at 9:00 A.M. IST on June 30, 2026, and ending at 5:00 P.M. IST on July 29, 2026. The notice and related documents were also hosted on the company’s website and the NSDL platform for transparency.

Regulatory Compliance and Next Steps

The proceedings adhered to multiple regulatory frameworks, including various Ministry of Corporate Affairs (MCA) circulars issued between 2020 and 2025 regarding e-voting procedures. Specifically, the company followed General Circular Nos. 14/2020, 17/2020, 22/2020, 33/2020, 39/2020, 10/2021, 20/2021, 3/2022, 11/2022, 09/2023, 09/2024, and 03/2025.

As of the conclusion date, the Scrutinizer’s report containing the detailed voting results is awaited. Once received, the Chairman or an authorized representative will declare the results. The company must then intimate the stock exchanges within the statutory timeline prescribed under SEBI LODR Regulations. If passed, the resolutions will be deemed effective as of July 29, 2026, subject to achieving the requisite majority.

JHS Svendgaard Laboratories Limited has initiated a postal ballot process to seek shareholder approval for revising the utilization of proceeds raised through a preferential issue. The total estimated utilization amount remains unchanged at ₹2,999.99 lakh, with funds proposed to be redirected towards broader capital expenditure, business expansion, and strategic growth initiatives by March 31, 2027.

The Board of Directors approved the variation at its meeting held on June 25, 2026, subject to shareholder consent. This modification amends the objects previously sanctioned via postal ballot on June 23, 2025, which had itself altered the original approval from the Extra-Ordinary General Meeting held on July 04, 2024. The company has engaged National Securities Depository Limited (NSDL) to facilitate the remote e-voting facility.

Voting Timeline and Process

The remote e-voting period commences on Tuesday, June 30, 2026, at 9:00 A.M. (IST) and concludes on Wednesday, July 29, 2026, at 5:00 P.M. (IST). The results of the postal ballot will be deemed passed on the last date of voting, subject to requisite majority approval. Members whose names appear in the register of members or beneficial owners as on Friday, June 26, 2026, are eligible to participate.

Mr. Mohit Dahiya, Company Secretary in Practice and Proprietor at M/s. Dahiya & Associates, has been appointed as the Scrutinizer to ensure the process is conducted fairly. The notice and explanatory statement are available on the company's website and the websites of BSE and NSE.

Revised Utilization Objects

The revised plan consolidates the earlier allocation into three primary categories, extending the tentative timeline for utilization to March 31, 2027. The tables below outline the existing and revised allocation structures.

Existing Objects (as approved on June 23, 2025):

*Considering 100% conversion of Warrants into Equity Shares within the stipulated time.

Objects After the Proposed Amendment:

*Considering 100% conversion of Warrants into Equity Shares within the stipulated time.

Key Objectives of the Amendment

Capital Expenditure and Business Expansion

Funds under this head will support capital expenditure, infrastructure upgradation, resource sharing, and manufacturing and business development initiatives. This category absorbs the previous allocation for equipment acquisition and expands the scope to include broader business development activities.

Strategic, Financial and Growth Initiatives

This category encompasses strategic investments, acquisitions, expansion initiatives, and restructuring activities. The company may deploy these funds directly or through investments in group companies via loans, advances, inter-corporate deposits, or equity, in compliance with applicable laws. The Board noted that the modification is clarificatory, intended to offer greater flexibility while achieving the original fundamental objectives.